Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
Excipients
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester...
Ingredient(s) : Poly DL Lactide
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA...
Ingredient(s) : Poly DL Lactide co Glycolide
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid; Polyethylene Glycol Excipients
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester...
Ingredient(s) : Poly L Lactide
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactide; Polyethylene Glycol Excipient
Excipients by Ingredients
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester...
Ingredient(s) : Poly L Lactide
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactide; Polyethylene Glycol Excipient
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid; Polyethylene Glycol Excipients
Excipients By applications
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester...
Ingredient(s) : Poly DL Lactide
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA...
Ingredient(s) : Poly DL Lactide co Glycolide
Dosage Form : Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release, Parenteral
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester...
Ingredient(s) : Poly L Lactide
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?